Showing results (101-110 of 301) with videos related to
Sort By:
Pageof 31
Pharmaceutical Medicine|January 15, 2020
Agomelatine Drug Utilisation Study in Selected European Countries: A Multinational, Observational Study to Assess Effectiveness of Risk-Minimisation MeasuresEmmanuelle Jacquot, Estelle Collin, Amy Ladner, et al.Pharmaceutical Medicine|January 15, 2020
ICD-11: Impact on Traditional Chinese Medicine and World Healthcare SystemsWai Ching Lam, Aiping Lyu, Zhaoxiang BianPharmaceutical Medicine|January 15, 2020
Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More FrequentlyMarsha A Wilcox, Jill Hardin, James Weaver, et al.Pharmaceutical Medicine|January 15, 2020
Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?Marc Maliepaard, Anne C Taams, Cynthia Sung, et al.Pharmaceutical Medicine|January 15, 2020
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DateSomaya Albhaisi, Arun J SanyalPharmaceutical Medicine|January 15, 2020
Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol EffluxDmitry Y Litvinov, Eugeny V Savushkin, Alexander D DergunovPharmaceutical Medicine|January 15, 2020
The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After ApprovalElisa Martín-Merino, Ana Llorente-García, Belén Castillo Cano, et al.Pharmaceutical Medicine|January 15, 2020
RETRACTED ARTICLE: The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 6 Years After ApprovalElisa Martín-Merino, Ana Llorente-García, Dolores Montero Corominas, et al.Pharmaceutical Medicine|January 15, 2020
Danish Physicians' Views on the Appropriateness of the Involvement of Patients with Type 2 Diabetes in Regulatory Decision Making: A Qualitative StudyMikkel Lindskov Sachs, Morten Colding-Jørgensen, Per Helboe, et al.Pharmaceutical Medicine|January 15, 2020
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional SurveyJoanna Lem, Muhammad Younus, Jalal A Aram, et al.Pageof 31